MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/bjc.2015.286

Медицинская библиотека · British journal of cancer · 2015

Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis.

Kirschner Michaela B, Pulford Emily, Hoda Mir Alireza, Rozsas Anita, Griggs Kim, Cheng Yuen Yee, Edelman J James B, Kao Steven C, Hyland Rebecca, Dong Yawen, László Viktoria, Klikovits Thomas, Vallely Michael P, Grusch Michael, Hegedus Balazs, Dome Balazs, Klepetko Walter, van Zandwijk Nico, Klebe Sonja, Reid Glen

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Fibulin-3 (FBLN3) was recently presented as a promising novel biomarker for malignant pleural mesothelioma (MPM), warranting independent validation studies.

METHODS

ELISA was used to measure cellular and secreted FBLN3 in cell lines, in plasma of xenograft tumour-bearing mice, in plasma from two independent series of MPM and non-MPM patients and in pleural fluid from a third series. Diagnostic and prognostic potential of FBLN3 was assessed by receiver operating characteristics curve analysis and Kaplan-Meier method, respectively.

RESULTS

FBLN3 was expressed in all MPM and benign mesothelial cell lines tested, and a correlation was observed between cellular protein expression and secreted levels. Human FBLN3 was detectable in plasma of tumour-bearing mice, suggesting that MPM cells contribute to levels of circulating FBLN3. Plasma FBLN3 was significantly elevated in MPM patients from the Sydney cohort, but not the Vienna cohort, but the diagnostic accuracy was low (63%, (95% CI: 50.1-76.4) and 56% (95% CI: 41.5-71.0), respectively). Although FBLN3 levels in pleural effusions were not significantly different between cases and controls, FBLN3 levels in pleural effusion fluid were found to be independently associated with prognosis (hazard ratio of 9.92 (95% CI: 2.14-45.93)).

CONCLUSIONS

These data confirm the potential prognostic value of pleural effusion FBLN3, but question the diagnostic value of this protein in MPM patients.

Для цитирования: Kirschner Michaela B, Pulford Emily, Hoda Mir Alireza, Rozsas Anita, Griggs Kim, Cheng Yuen Yee, Edelman J James B, Kao Steven C, Hyland Rebecca, Dong Yawen, László Viktoria, Klikovits Thomas, Vallely Michael P, Grusch Michael, Hegedus Balazs, Dome Balazs, Klepetko Walter, van Zandwijk Nico, Klebe Sonja, Reid Glen. Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis.. British journal of cancer. 2015. DOI: 10.1038/bjc.2015.286.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.